Background: Various bodily tissues have been reported to enter the arterial circulation and embolise to the brain resulting in ischaemic stroke. Most frequently non-thrombotic, embolic stroke (NTES) of tissue origin is iatrogenic or related to an underlying disease process. With the increase in elective surgery and intravascular procedures, NTES may increase in prevalence.
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Aim: To compile a summary of the Background, incidence, presentation and treatment of NTES of tissue origin, by conducting a systematic review of the current literature. Summary of Review: We searched EMBASE and MEDLINE for articles on NTES of tissue origin published in English with no restriction on publication date (search date March 2016). 787 articles were identified and screened and 150 articles were ultimately reviewed in full text and included in qualitative analysis. Articles deemed relevant were assessed by a second reviewer to confirm compatibility with the inclusion criteria. References of included articles were reviewed for relevant publications. We categorised the pathology of the emboli into the following groups: amniotic fluid (2 reports), tumour (43 reports), fat (49 reports), cholesterol (12 reports) and intravascular debris. We then summarised the available literature on each of these causes of NTES. Conclusions: NTES of tissue origin is an uncommon but important diagnosis to consider particularly in younger stroke patients and in certain clinical settings. Treatment for NTES is currently anecdoctal and based on small case series. Embolectomy may emerge as the therapy of choice due to the longer treatment timeframe and heterogeneity of the emboli.
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